AVIR·04683R106·US·equity·Healthcare - Biotechnology-Activist
AVIR (ATEA PHARMACEUTICALS INC) is held by 82 institutional investors as of Q1 2026. Largest holders: FMR LLC ($64.3M), BlackRock, Inc. ($45.4M), TWO SIGMA INVESTMENTS, LP ($10M). Net institutional sentiment: Mixed.
See how AVIR's score breaks down across 4 SEC sources
Showing 1-20 of 87
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer